" class="no-js "lang="en-US"> Jinzi J. Wu - Medtech Alert
Monday, November 11, 2024
Jinzi J. Wu

Jinzi J. Wu

About Jinzi J. Wu

Dr. Jinzi J. Wu is the Founder and CEO of Gannex which was founded in 2019, a wholly-owned company of Ascletis(1672.HK). Dr. Wu has more than 20-year experience covering R&D, GMP manufacturing and commercialization in Big Pharma and biotech. Prior to founding Ascletis and Gannex, he was the Vice President at GSK R&D in USA. He also held various R&D positions from Sr. Scientist to Vice President at Novartis, Immunex/Amgen and Ambrilia in USA and Canada. Dr. Wu obtained his Ph.D. in Cancer Biology from University of Arizona.

Related Story

Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication

January 27 2023

Ascletis Pharma announces that the China National Medical Products Administration (NMPA) has approved the Investigational […]

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors

August 8 2022

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) today announces the completion of first patient dosing in […]